 I N V E S T M E N T S
Visiometrics
Visiometrics S.L. was founded in 2001 based on the results of a research made by the "Universitat Politècnica de Catalunya" in collaboration with the "Laboratorio de Óptica de la Universidad de Murcia". The research works, started in 1996, are focused in the development of a new technique to evaluate the optical quality of human vision
At the moment, VISIOMETRICS is marketing the OQAS (Optical Quality Analysis System) which enables the analysis of the optical quality of the images formed in the patients' retina. The measurements are made objectively, that is to say, without needing the patients answer. We find its main application in the refractive surgery field and in the elderly ocular illness diagnosis.
Among the currently developing projects that will soon be available on the market, we find a new sensor to measure eye aberrations and a very precise automatic binocular eye-tracker (or "pupilometer") based on the registration and treatment of pupil images. The new aberration sensor might be implemented in the OQAS system allowing the simultaneous measurement of the retina's image quality and the eye aberrations, becoming a worldwide instrumental innovation.
|
 |
AIDA CENTRE RFID Solutions
AIDA Centre S.L., incorporated in June 2004, is dedicated to the design, commercialisation and implantation of solutions based in the radio frequency identification technology (RFIF), also known as "electronic labelling".
The technology of radio frequency auto-identification or, known also as "Radio Frequency Identification Devices" (RFID), is based on electronic labels or tags formed by a chip and a little antenna that perform a similar function to bar codes, but with important advantages. These labels can be attached to all products and make it possible to distantly identify and control them all along the distribution chain, from the manufacturer to the customer, and in addition, they enable to store multiple data concerning such products.
|
 |
GENMEDICA THERAPEUTICS
Genmedica Therapeutics is a Barcelona-based biotechnology company currently in the process of being formed. The Company will focus on the discovery and development of innovative human therapeutics for diseases within the so-called metabolic syndrome, namely, diabetes, obesity and inflammatory and cardiovascular diseases.
In many Western nations, metabolic syndrome diseases currently affect about 20% of the population and are growing at epidemic rates. Recent epidemiological and biological data suggest that the etiologies of these diseases share unexpected and overlapping genetic and biochemical mechanisms, thus offering synergy in the discovery and development of therapeutics of otherwise unrelated diseases. This overlap in biology is the focus of Genmedica's drug discovery and development efforts.
Genmedica's lead drug candidates are oral therapies for diabetes type 1 and 2 that represent a new class of potential diabetes therapies, and a novel class of anti-inflammatory compounds. These drug candidates are currently in pre-clinical studies.
Genmedica Therapeutics is being run by CEO Alec Mian and strives to be capital efficient and quasi-virtual with minmal office and laboratory space in Barcelona, Spain.
|
 |
Comercial TV
Comercial TV es una distribuidora de contenidos audiovisuales que nace para dar servicio a las TV Locales con el objetivo de convertirse en el proveedor de referencia del sector.
En Comercial TV creemos en la Televisión Local y en su enorme potencial de futuro como medio de comunicación de proximidad y como soporte publicitario y comercial.
Por eso pensamos que era necesario crear un sistema que permitiera a las Televisiones Locales acceder, fácilmente y con un coste ajustado a su realidad,
a los mejores contenidos audiovisuales y con la mejor calidad. Los contenidos que Comercial TV ofrece a las Televisiones Locales en tiempo real les ayudarán
a consolidar el crecimiento de la Televisión Local y a fidelizar a sus audiencias. Además, les permitirán competir en mejores condiciones con otros medios
de comunicación y con otros soportes publicitarios.
Comercial TV ofrece un catálogo amplio y cuidado de títulos de todos los géneros de los proveedores más destacados y reconocidos del panorama audiovisual,
tanto nacional como internacional, y los pone on-line a disposición de las Televisiones Locales.
|
 |
SOM Biotech: The drug repositioning company
SOM Biotech (SOM) is a recently established start-up company at the Scientific Parc of Barcelona with the mission to discover and develop new indications of already known drugs (repositioning) through a profitable private company committed to its shareholders, employees and society. Repositioned drug access implies discovering, confirming, patenting and licensing already known drugs for their commercial use in respect to unknown medical uses. Our propietry discovery platform is based on an in-silico computerized approach and the drug development is driven by a dedicated team of experts and strategy advisors.
|
 |
|
Copyright © 2002-2008 by Innova31 S.C.R. S.A. - All rights reserved.
|
© 2002-2008, Website designed & developed by Nicolás Amado for Sonanvision®.
eBusiness & Usability Consulting by Nicolás Amado for Sonanvision®.
On-line Marketing by Nicolás Amado for Sonanvision®.
All Rights Reserved
|
|
